01446nam a2200337Ia 4500001001200000003000800012006001900020007001500039008004100054010001700095020004300112020003800155040002100193035002100214050002500235082001800260100003300278245013100311260005300442300002300495490004300518504005100561533015200612610005000764650004200814650003600856655002900892710001700921830004400938856012600982ebr10394772CaPaEBRm        u        cr cn|||||||||091106s2010    njua    sb    001 0 eng d  z  2009044230  z9780691141794 (hardcover : alk. paper)  z9780691141800 (pbk. : alk. paper)  aCaPaEBRcCaPaEBR  a(OCoLC)65534213314aRA401.A3bC37 2010eb04a362.17/822221 aCarpenter, Daniel P.,d1967-10aReputation and power organizational image and pharmaceutical regulation at the FDAh[electronic resource] /cDaniel Carpenter.  aPrinceton :bPrinceton University Press,cc2010.  axx, 802 p. :bill.1 aPrinceton studies in American politics  aIncludes bibliographical references and index.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2011.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries.10aUnited States.bFood and Drug Administration. 0aPharmaceutical policyzUnited States. 0aDrugsxResearchzUnited States. 7aElectronic books.2local2 aebrary, Inc. 0aPrinceton studies in American politics.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10394772zAn electronic book accessible through the World Wide Web; click to view